Literature DB >> 6652683

Crosslinking of proteins in acetylcholine receptor-rich membranes: association between the beta-subunit and the 43 kd subsynaptic protein.

S J Burden, R L DePalma, G S Gottesman.   

Abstract

Acetylcholine receptor-rich membranes from the electric organ of Torpedo californica are enriched in the four subunits (alpha, beta, gamma, delta) of the acetylcholine receptor (AChR) and for polypeptides at 43 kd and 270 kd. Reaction of these membranes with 3H-N-ethylmaleimide (3H-NEM) demonstrates that most of the available free sulfhydryls reside on the 43 kd protein. Cross-linking reagents that contain NEM as one reactive group, and N-hydroxysuccinimide as the other, were used to study the topography of the 43 kd protein in AChR-rich membranes. Proteins from cross-linked membranes were resolved by SDS-PAGE and the composition of crosslinked products was determined by Western blots and monoclonal antibodies. A crosslinked product at 110 kd was labeled by a monoclonal antibody to the beta-subunit and by a monoclonal antibody to the 43 kd protein, but not by monoclonal antibodies to the alpha, gamma, or delta subunits. The 110 kd crosslink was not produced in the presence of 10 mM lithium diiodosalicylate, which dissociates the 43 kd protein from the membrane. Thus the 43 kd protein is intimately associated with the AChR and in close proximity to the beta-subunit.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652683     DOI: 10.1016/0092-8674(83)90101-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  72 in total

1.  Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors.

Authors:  C Fuhrer; M Gautam; J E Sugiyama; Z W Hall
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Metabolic stabilization of muscle nicotinic acetylcholine receptor by rapsyn.

Authors:  Z Z Wang; A Mathias; M Gautam; Z W Hall
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

Review 3.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

4.  Src-class kinases act within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, cytoskeletal anchoring, and clustering.

Authors:  A S Mohamed; K A Rivas-Plata; J R Kraas; S M Saleh; S L Swope
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 5.  Nicotinic receptor-associated 43K protein and progressive stabilization of the postsynaptic membrane.

Authors:  J A Hill
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

6.  The myristoylated protein rapsyn is cotargeted with the nicotinic acetylcholine receptor to the postsynaptic membrane via the exocytic pathway.

Authors:  S Marchand; F Bignami; F Stetzkowski-Marden; J Cartaud
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

7.  14-3-3 gamma associates with muscle specific kinase and regulates synaptic gene transcription at vertebrate neuromuscular synapse.

Authors:  Laure Strochlic; Annie Cartaud; Alexandre Mejat; Régis Grailhe; Laurent Schaeffer; Jean-Pierre Changeux; Jean Cartaud
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

8.  The role of the cytoskeleton in neuromuscular junction formation.

Authors:  G Clement Dobbins; Bin Zhang; Wen C Xiong; Lin Mei
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 9.  Ligand-gated ion channels. Homology and diversity.

Authors:  V B Cockcroft; D J Osguthorpe; E A Barnard; A E Friday; G G Lunt
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 10.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.